Red ListRecovering

RNACCartesian Therapeutics, Inc.

Healthcare · Biotechnology · micro-cap ($164M)
-53.7%
from rolling 252-day high of $15.57 set 2025-07-09 · 323d ago
Current
$7.21
Decline depth
-53.7%
Decline σ
4.4σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$RNAC has been tracked since 2026-03-01. It was down 59.9% from its 52-week high then — now down -53.7%.

It has clawed back 9.6 percentage points off that level. It bottomed 69.2% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

RNAC qualifies for the Red List on decline depth.

Decline depth
-53.7%
From rolling 252-day high of $15.57, 323d ago. Past the 40% Red List threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
4.4σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (6.67% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about RNAC.

RNAC qualifies for the Red List on decline depth — down -53.7% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 4.4σ over 20 bars.

Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.

Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether RNAC's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.

Upstream TFC read: strong alignment, current phase daily. Last bar types — daily 2U (green), weekly 2D (green), monthly 2U (green).

Earnings on file: 2026-03-09. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $5.60 16.1% of range 52W high $15.57

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

88 Red List
47 Amber
59 Watch
-35.8% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about RNAC

What people ask.

Why is RNAC on Broken Stocks?

RNAC qualifies for the Red List on decline depth. It is down -53.7% from its rolling 252-day high of $15.57, set on 2025-07-09 — 323d ago. It additionally carries a Recovering badge — see below.

What does the Recovering badge mean for RNAC?

Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — RNAC is still Red List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.

Is RNAC a falling knife?

Not by the strict technical definition. RNAC is down -53.7% from its 52-week high, but that high was set 323d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. RNAC is still on the Red List for decline depth, but the freshness component of a falling knife is missing.

Is RNAC a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is RNAC trading inside its 52-week range?

At $7.21, RNAC sits 16.1% of the way from its 52-week low ($5.60) to its 52-week high ($15.57). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has RNAC been declining?

The current 53.7% decline accrued over 323d, which annualizes to roughly -60.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does RNAC compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 88 Red, 47 Amber, 59 Watch, with 107 showing recovering structural signals. Median sector decline is -35.8% — RNAC's decline is deeper than the sector median.

Does RNAC's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-03-09) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.